Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,921 | 13,376 | 67,907 | 34,959 | 16,255 |
| Marketable Securities | 283,491 | 224,265 | 94,396 | 70,622 | 24,397 |
| Receivables | 167 | 392 | 25,000 | N/A | N/A |
| TOTAL | $330,034 | $240,993 | $192,013 | $107,101 | $42,302 |
| Non-Current Assets | |||||
| PPE Net | 1,484 | 1,584 | 1,716 | 1,785 | 1,552 |
| Investments And Advances | 40,556 | 35,481 | 52,866 | 25,549 | 0 |
| Other Non-Current Assets | 7,778 | 8,628 | 9,305 | 9,655 | 10,239 |
| TOTAL | $49,818 | $45,693 | $63,887 | $36,989 | $11,791 |
| Total Assets | $379,852 | $286,686 | $255,900 | $144,090 | $54,093 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,380 | 4,622 | 2,526 | 418 |
| Accounts payable and accrued liabilities | 3,593 | 4,286 | 3,349 | 582 | 1,543 |
| Accrued Expenses | 21,187 | 14,003 | 9,417 | 5,777 | 5,285 |
| TOTAL | $41,980 | $57,996 | $69,778 | $41,167 | $8,681 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 3,380 | 7,602 | 4,509 |
| Deferred Revenues | 16,288 | 35,571 | 51,773 | 31,627 | 1,435 |
| Other Non-Current Liabilities | 9,002 | 10,085 | 11,009 | 11,815 | 11,429 |
| TOTAL | $9,931 | $49,270 | $65,219 | $40,765 | $15,938 |
| Total Liabilities | $51,911 | $107,266 | $134,997 | $81,932 | $24,619 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,546 | 47,757 | 30,294 | 23,882 | 18,588 |
| Common Shares | 60 | 46 | 30 | 24 | 19 |
| Retained earnings | -256,145 | -223,961 | -166,199 | -115,866 | -87,926 |
| Other shareholders' equity | 397 | -1,121 | -273 | 53 | 10 |
| TOTAL | $327,941 | $179,420 | $120,903 | $62,158 | $29,474 |
| Total Liabilities And Equity | $379,852 | $286,686 | $255,900 | $144,090 | $54,093 |